Skip to main content
Premium Trial:

Request an Annual Quote

Pentabase Receives $339K from Angel Investor

NEW YORK (GenomeWeb News) – Odense, Denmark-based PentaBase has received DKK 2 million (US$339,000) from an unnamed angel investor, the firm said this week.
 
PentaBase, which is developing molecular diagnostics and sells real-time PCR-based probes, said that the funding will be used to increase sales of its platform technologies, services, and diagnostic tests for infectious diseases. The firm also offers DNA sequencing services.
 
PentaBase said that the funding came from an anonymous Danish business investor, “who previously [had] experienced similar challenges to those that PentaBase currently have.”
 
“This funding will primarily be used to increase our sales activities of existing products and the development and protection of our patent portfolio,” PentaBase Founder and CEO Ulf Bech Christensen said in a statement.
 
Pentabase was founded in 2006 and is developing diagnostic tools for influenza, avian flu, and cancer-related diseases.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.